Context Cash And Short Term Investments from 2010 to 2024

CNTX Stock  USD 1.36  0.03  2.16%   
Context Therapeutics Cash And Short Term Investments yearly trend continues to be fairly stable with very little volatility. Cash And Short Term Investments are likely to outpace its year average in 2024. Cash And Short Term Investments is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. View All Fundamentals
 
Cash And Short Term Investments  
First Reported
2010-12-31
Previous Quarter
14.4 M
Current Value
22 M
Quarterly Volatility
15.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Context Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Context Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 435.1 K, Selling General Administrative of 9.1 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.6. Context financial statements analysis is a perfect complement when working with Context Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Context Therapeutics Correlation against competitors.
For more information on how to buy Context Stock please use our How to Invest in Context Therapeutics guide.

Latest Context Therapeutics' Cash And Short Term Investments Growth Pattern

Below is the plot of the Cash And Short Term Investments of Context Therapeutics over the last few years. Short Term Investments is an account in the current assets section of Context Therapeutics balance sheet. This account contains Context Therapeutics investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Context Therapeutics fairly quickly. It is the sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash. Context Therapeutics' Cash And Short Term Investments historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Context Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Cash And Short Term Investments10 Years Trend
Slightly volatile
   Cash And Short Term Investments   
       Timeline  

Context Cash And Short Term Investments Regression Statistics

Arithmetic Mean8,281,504
Geometric Mean836,165
Coefficient Of Variation187.90
Mean Deviation11,798,597
Median226,603
Standard Deviation15,560,603
Sample Variance242.1T
Range49.4M
R-Value0.63
Mean Square Error157.8T
R-Squared0.40
Significance0.01
Slope2,186,843
Total Sum of Squares3389.9T

Context Cash And Short Term Investments History

202422 M
202314.4 M
202235.5 M
202149.6 M
2020341 K

About Context Therapeutics Financial Statements

Context Therapeutics investors use historical fundamental indicators, such as Context Therapeutics' Cash And Short Term Investments, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Context Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash And Short Term Investments14.4 M22 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Context Stock Analysis

When running Context Therapeutics' price analysis, check to measure Context Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Context Therapeutics is operating at the current time. Most of Context Therapeutics' value examination focuses on studying past and present price action to predict the probability of Context Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Context Therapeutics' price. Additionally, you may evaluate how the addition of Context Therapeutics to your portfolios can decrease your overall portfolio volatility.